Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ...

Dewpoint Therapeutics CEO Ameet Nathwani stated: “This partnership underscores the transformative potential of our small ...

The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...

Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...

Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

When clouds are missing, a tree, a car, or any other object will do. The canopy provided by a tree can prevent heat from ...

Under the terms of the agreement, Dewpoint will receive an upfront payment and will be eligible for milestone payments based on specified near-term research and development objectives, with a total ...

Stellaris Venture Partners founders reveal the secret to its winning VC plays. Ambiator offers alternative cooling solutions ...

New Mexico is off to a calm start this afternoon. The state is expected to remain dry for the rest of the day as temperatures ...